Association between ibrutinib and mid-cavitary Takotsubo cardiomyopathy: a case report and a review of chemotherapy-induced Takostubo’s cardiomyopathy-Reference-Cited by-同舟云学术

Association between ibrutinib and mid-cavitary Takotsubo cardiomyopathy: a case report and a review of chemotherapy-induced Takostubo’s cardiomyopathy

Published:2017-11-02 Issue:2 Volume:1 Page:
ISSN:2514-2119
Container-title:European Heart Journal - Case Reports
language:en
Short-container-title:

Author:

Giza Dana Elena¹,Moudgil Rohit¹,Lopez-Mattei Juan¹,Kim Peter¹,Iliescu Cezar¹

Affiliation:

1. Department of Cardiology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, 77030 TX, USA

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/ehjcr/article-pdf/1/2/ytx006/28121971/ytx006.pdf

Reference49 articles.

1. Proposed Mayo Clinic criteria for the diagnosis of Tako-Tsubo cardiomyopathy and long-term prognosis;Madhavan;Herz,2010

2. Apical ballooning syndrome: an important differential diagnosis of acute myocardial infarction;Prasad;Circulation,2007

3. Capecitabine-induced Takotsubo cardiomyopathy: a case report and literature review;Qasem;. Am J Ther,2016

4. 5-Fluorouracil-induced Tako-Tsubo-like syndrome;Basselin;Pharmacotherapy,2011

5. Takotsubo cardiomyopathy after systemic consolidation therapy with high-dose intravenous cytarabine in a patient with acute myeloid leukemia;Baumann;Oncol Res Treat,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ibrutinib, a Bruton's tyrosine kinase inhibitor, regulates ventricular electromechanical activities and enhances arrhythmogenesis;European Journal of Pharmacology;2024-08

2. Chronic Lymphocytic Leukemia: Management of Adverse Events in the Era of Targeted Agents;Cancers;2024-05-24

3. Cardiotoxicity of anti-cancer drugs: cellular mechanisms and clinical implications;Frontiers in Cardiovascular Medicine;2023-09-08

4. Cardiovascular Toxicities of Ibrutinib: A Pharmacovigilance Study Based on the United States Food and Drug Administration Adverse Event Reporting System Database;Pharmaceuticals;2023-01-09

5. Ibrutinib-Associated Cardiotoxicity: From the Pharmaceutical to the Clinical;Drug Design, Development and Therapy;2022-09